Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

NACompletedINTERVENTIONAL

Enrollment

166

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Chronic Hepatitis B

Interventions

OTHER

blood draw

Trial Locations (11)

Montreal

Grenoble

Lyon

Nancy

Paris

Strasbourg

Freiburg im Breisgau

Hamburg

Hanover

Mainz

München